Women With Small Breast Tumours Could Also Benefit From Treatment With Trastuzumab (H
Trastuzumab (Herceptin) has revolutionised the care of HER2-positive (HER2+) early breast cancer* and is the standard treatment for tumours larger than 1cm. By contrast, most small (⤠1cm) breast cancers have a favourable prognosis and are widely believed not to benefit from adjuvant treatment (treatment given in addition to primary therapy)...
More... |
All times are GMT -7. The time now is 06:44 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021